GlassScriptPhysician profile
Bryce Gosney
NPI 1346993193
$1,219.35
in general payments reported to CMS, 2019-2025
14 companies · $844 in 2025
The $844 reported for 2025 was more than what 77% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $375 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $411.20 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $217.02 | 2024-2025 | Fanapt |
| Idorsia Pharmaceuticals US INC | $98.55 | 2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $95.13 | 2024-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $86.88 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $60.31 | 2024-2025 | Qelbree |
| Axsome Therapeutics, INC. | $59.19 | 2024-2025 | Auvelity |
| Alkermes, INC. | $55.59 | 2025 | Lybalvi, Aristada |
| Ironshore Pharmaceuticals INC. | $36.35 | 2024 | |
| Lundbeck LLC | $34.73 | 2025 | Rexulti |
| Collegium Pharmaceutical, INC. | $17.46 | 2025 | Jornay Pm |
| Biogen, INC. | $16.97 | 2025 | Zurzuvae |
| Tris Pharma INC | $15.18 | 2025 | Dyanavel Xr |
| Bausch Health US, LLC | $14.79 | 2025 | Aplenzin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Gosney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.